Literature DB >> 17338958

Castleman's disease: A rare lymphoproliferative disorder.

T E F Jongsma1, R J Verburg, P H L M Geelhoed-Duijvestijn.   

Abstract

Castleman's disease (CD) is an atypical lymphoproliferative disorder. Since it was first described in 1956, it has been referred to as follicular lympho-reticuloma, angiofollicular mediastinal lymph node hyperplasia, and benign giant lymphoma. CD is a heterogeneous disease that can be either localized or systemic (multicentric). The localized form can be divided into two types: the hyaline-vascular (HV) type or the plasma cell (PC) type. The former usually produces few symptoms and histological features include abnormal follicles and increased interfollicular vascularity. The PC type, in which, histopathologically, the presence of sheets of mature plasma cells is the distinguishing feature, is more likely to produce clinical symptoms such as fever, night sweats, and lymphadenopathy. The multicentric form mimics the PC type of localized CD, and patients present with systemic symptoms. In this report, we discuss the spectrum of clinical and pathological findings in localized and multicentric CD.

Entities:  

Year:  2007        PMID: 17338958     DOI: 10.1016/j.ejim.2006.09.019

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  13 in total

1.  Incidental finding of Castleman's disease in an asymptomatic young adult.

Authors:  Ibrahim Shahbuddin; Damian McKeon
Journal:  BMJ Case Rep       Date:  2009-12-09

2.  Castleman's Disease: a Suprarenal Surprise!

Authors:  Praveen Sundar; Priyank Bijalwan; Ginil Kumar Pooleri
Journal:  Indian J Surg Oncol       Date:  2018-03-17

Review 3.  Castleman's disease: systematic analysis of 416 patients from the literature.

Authors:  Nadia Talat; Klaus-Martin Schulte
Journal:  Oncologist       Date:  2011-07-17

4.  Successful treatment of multicentric Castleman's disease accompanying myeloma with bortezomib.

Authors:  Afaq Ahmad Khan; Fouzia Siraj; Manorama Bhargava; Shyam Aggarwal
Journal:  BMJ Case Rep       Date:  2012-12-20

5.  Castleman's disease of a submandibular mass diagnosed on Fine Needle Cytology: Report of a case with histopathological, immunocytochemical and imaging correlations.

Authors:  Maria Gabriella Malzone; Anna Cipolletta Campanile; Veronica Sanna; Franco Ionna; Francesco Longo; Annarosaria De Chiara; Sergio Venanzio Setola; Gerardo Botti; Franco Fulciniti
Journal:  Intractable Rare Dis Res       Date:  2016-02

6.  Mesenteric Castleman's disease in a 12-year-old girl.

Authors:  Fei Fei Li; Tao Zhang; Yu Zuo Bai
Journal:  J Gastrointest Surg       Date:  2011-05-10       Impact factor: 3.452

7.  Thymoma of the middle mediastinum.

Authors:  Su Ryeun Chung; In Sook Kim; Jhingook Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-08-03

8.  Primary mediastinal Castleman's disease.

Authors:  Mohamed A H Regal; Yasser M Aljehani; Hanan Bousbait
Journal:  Rare Tumors       Date:  2010-03-31

9.  Treatment of multicentric Castleman's Disease accompanying multiple myeloma with bortezomib: a case report.

Authors:  Zhen-gang Yuan; Xiao-yi Dun; Yong-hua Li; Jian Hou
Journal:  J Hematol Oncol       Date:  2009-04-28       Impact factor: 17.388

10.  Radiation therapy in the treatment of unicentric Castleman's disease.

Authors:  Fabiana Accioli Miranda; Victor Hugo Chiquetto Faria; Gustavo Viani Arruda; Lucas Godoi Bernardes da Silva
Journal:  J Bras Pneumol       Date:  2013 Jan-Feb       Impact factor: 2.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.